Security Snapshot

INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) Institutional Ownership

CUSIP: 457985208

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

208

Shares (Excl. Options)

73,233,407

Price

$17.96

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-1,135,167
Value change
+$593,199
Number of holders
208
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
77,807,647
SEC-reported price per share
$18.58
Insider filing price
$18.58
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • IART - INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock is tracked under CUSIP 457985208.
  • 208 institutions reported positions in Q2 2026.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 202 to 208 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $704,716,764 to $1,314,783,927.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 208 institutions filings for Q2 2026.

Open SEC evidence

Security key

457985208

Latest holder period

Q2 2026

13F holders

208

13D/G owners

7

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
7
Security
IART
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 13% $126,168,790 10,282,705 BlackRock, Inc. 30 Jun 2025
Rubric Capital Management LP 9.5% +58% $90,232,770 +$33,254,915 7,353,934 +58% Rubric Capital Management LP 30 Jun 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 5% $72,700,121 3,912,816 Vanguard Portfolio Management 30 Jun 2026
FULLER & THALER ASSET MANAGEMENT, INC. 4.7% $45,163,591 3,636,360 Fuller & Thaler Asset Management, Inc. 31 Dec 2025
Invesco Ltd. 4.5% -16% $50,024,712 -$8,895,949 3,490,908 -15% Invesco Ltd. 30 Sep 2025
PARADIGM CAPITAL MANAGEMENT INC/NY 4.4% $63,898,441 3,439,098 PARADIGM CAPITAL MANAGEMENT INC/NY 31 Mar 2026
MORGAN STANLEY 4.3% $42,546,659 3,379,401 Morgan Stanley 30 Jun 2025

As of 30 Jun 2026, 208 institutional investors reported holding 73,233,407 shares of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART). This represents 94% of the company’s total 77,807,647 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
80%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 14% 10,684,103 +3.5% 0% $191,886,488
Rubric Capital Management LP 10% 7,753,934 0% 1.3% $139,260,655
Invesco Ltd. 4.8% 3,749,367 +7.6% 0.01% $67,338,631
VANGUARD PORTFOLIO MANAGEMENT LLC 4.8% 3,743,093 +1.5% 0% $67,225,950
MORGAN STANLEY 4.6% 3,593,078 +0.25% 0% $64,531,693
PARADIGM CAPITAL MANAGEMENT INC/NY 4.4% 3,439,098 -14% 1.7% $61,766,200
FULLER & THALER ASSET MANAGEMENT, INC. 4.4% 3,436,006 -2.6% 0.17% $61,710,664
STATE STREET CORP 3.8% 2,946,862 +2.1% 0% $52,925,642
VANGUARD CAPITAL MANAGEMENT LLC 3.8% 2,946,173 +1.9% 0% $52,913,267
NEUBERGER BERMAN GROUP LLC 3% 2,364,777 +12% 0.03% $42,626,533
DIMENSIONAL FUND ADVISORS LP 2.8% 2,216,653 -20% 0.01% $39,814,517
GEODE CAPITAL MANAGEMENT, LLC 2.3% 1,791,635 +8.1% 0% $32,183,715
GOLDMAN SACHS GROUP INC 1.9% 1,473,719 -21% 0% $26,467,994
WELLINGTON MANAGEMENT GROUP LLP 1.9% 1,461,104 +12% 0% $26,241,429
MILLENNIUM MANAGEMENT LLC 1.9% 1,439,747 +131% 0.02% $25,857,856
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.8% 1,401,476 -13% 0% $25,170,509
BANK OF AMERICA CORP /DE/ 1.7% 1,329,251 -6% 0% $23,873,348
SYSTEMATIC FINANCIAL MANAGEMENT LP 1.3% 1,023,243 -3.4% 0.37% $18,377,461
Allianz Asset Management GmbH 1.3% 1,005,203 +13% 0.02% $18,053,446
GLENMEDE TRUST CO NA 1.2% 948,142 -3.7% 0.08% $17,028,630
NORTHERN TRUST CORP 1.1% 828,532 +8.3% 0% $14,880,435
Balyasny Asset Management L.P. 0.82% 640,666 -7.7% 0.02% $11,506,361
Quantinno Capital Management LP 0.78% 609,132 +33% 0.01% $10,940,011
Invenomic Capital Management LP 0.74% 579,036 -43% 0.62% $10,399,487
Integral Health Asset Management, LLC 0.71% 550,000 0.41% $9,878,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 73,233,407 $1,314,783,927 +$593,199 $17.96 208
2026 Q1 74,797,104 $704,716,764 +$4,872,235 $9.42 202
2025 Q4 73,967,449 $919,385,712 +$13,984,006 $12.42 205
2025 Q3 72,842,524 $1,043,672,317 -$4,151,749 $14.33 206
2025 Q2 73,128,875 $897,334,015 -$36,927,297 $12.27 208
2025 Q1 73,527,026 $1,616,422,067 +$95,408,342 $21.99 217
2024 Q4 69,341,057 $1,572,669,168 +$40,392,223 $22.68 221
2024 Q3 68,356,958 $1,241,956,268 -$123,869,325 $18.17 221
2024 Q2 70,995,999 $2,068,211,745 +$111,506,222 $29.14 236
2024 Q1 65,939,547 $2,336,158,778 -$70,993,946 $35.45 276
2023 Q4 66,935,797 $2,915,003,332 -$77,019,585 $43.55 283
2023 Q3 68,807,037 $2,627,769,882 -$14,108,008 $38.19 261
2023 Q2 68,833,788 $2,831,315,238 -$177,674,783 $41.13 276
2023 Q1 72,805,512 $4,179,487,921 -$119,683,717 $57.41 276
2022 Q4 74,882,267 $4,198,618,336 +$359,984,223 $56.07 274
2022 Q3 73,865,761 $3,129,594,394 +$18,803,141 $42.36 267
2022 Q2 73,142,507 $3,952,123,032 -$58,765,680 $54.03 274
2022 Q1 74,668,149 $4,798,437,509 -$193,114,447 $64.26 270
2021 Q4 77,374,227 $5,183,843,022 +$22,566,888 $66.99 266
2021 Q3 76,845,573 $5,262,770,593 +$142,772,975 $68.48 249
2021 Q2 74,753,608 $5,101,379,862 +$63,654,057 $68.24 256
2021 Q1 73,827,696 $5,100,654,311 -$19,956,840 $69.09 251
2020 Q4 74,131,946 $4,812,746,680 +$106,065,718 $64.92 242
2020 Q3 72,733,580 $3,434,003,702 +$24,582,537 $47.22 227
2020 Q2 72,219,818 $3,393,083,524 +$38,047,204 $46.99 258
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .